Uveitis may be the cause if you experience eye pain, redness, blurred vision, light sensitivity, and floaters. The rare, complex condition can result in chronic inflammation in the front, middle or back of the eye. Uveitis can lead to in vision impairment, glaucoma, cataracts, or retinal swelling. Active inflammation requires immediate care by an experienced ophthalmologist.
Duke's team of uveitis specialists ensure you get the proper diagnosis and comprehensive care to reduce active uveitis inflammation and preserve your vision. At the same time, we help you manage the complications that are sometimes associated with uveitis treatments.
Duke Health offers locations throughout the Triangle. Find one near you.
These tests look for inflammatory, autoimmune, and infectious causes of uveitis.
Fluid samples from the eye can sometimes help identify the cause of uveitis. An aqueous fluid sample may be obtained from the front of the eye during a clinic visit. A vitreous sample may be obtained from the back of the eye during vitrectomy surgery in the operating room.
Various types of retinal imaging, often combined with a dye injection (angiography), can confirm a diagnosis of uveitis, document lesions and scarring, and monitor the progression of uveitis.
Looks for signs of sarcoidosis or tuberculosis.
Why Choose Duke
Advanced Training and Experience
The Duke uveitis clinic is staffed by ophthalmologists with advanced training and experience in managing uveitis, as well as experts in glaucoma, cataracts, and retinal disease. A rheumatologist is also on staff. We coordinate your appointments so you can meet with these and other specialists as needed.
Infectious uveitis often requires specific treatment tailored to the infection. Duke’s uveitis specialists use specially compounded medications that are not readily available to treat different types of eye infections.
Learning to Manage Your Condition
Your care includes education about your condition, and access to our low vision rehabilitation program, which offers tools for living with impaired vision. Our dedicated social worker is also available to help you and your loved ones manage your care and maximize your quality of life.
Over 30 Years of Innovative Research
Duke’s uveitis specialists have been studying effective uveitis treatments for more than 30 years. We were instrumental in the development of a new steroid delivery system and were involved in the clinical trials that led to the 2016 FDA approval of the non-steroidal biologic drug Humira (adalimumab) to treat uveitis. We continue to participate in clinical trials and research to broaden our understanding of uveitis and effective treatments.